Magnetar Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,292
Closed -$217K – 1761
2026
Q2
$217K Buy
+8,292
New +$211K ﹤0.01% 914
2025
Q3
– Sell
-12,168
Closed -$153K – 1238
2025
Q2
$153K Sell
12,168
-280
-2% -$3.34K ﹤0.01% 825
2025
Q1
$148K Buy
+12,448
New +$170K ﹤0.01% 691
2019
Q1
– Sell
-15,000
Closed -$220K – 478
2018
Q4
$220K Sell
15,000
-10,055
-40% -$132K 0.01% 230
2018
Q3
$393K Buy
25,055
+55
+0.2% +$787 0.01% 248
2018
Q2
$370K Buy
+25,000
New +$387K 0.01% 331

Other funds holding ZYME

Magnetar Financial's ZYME Position: Q3 2026 in Review

Magnetar Financial sold out of Zymeworks (ZYME) in Q3 2026, closing a stake of 8,292 shares — an estimated $217K sold.

Magnetar Financial first reported a position in ZYME in Q2 2018 and held it in 6 quarters. The position peaked at $393K in Q3 2018. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Magnetar Financial reported no remaining Zymeworks position as of Q3 2026 after selling out during the quarter.
  • Magnetar Financial sold 8,292 Zymeworks shares in Q3 2026, an estimated $217K.
  • Magnetar Financial first reported a position in Zymeworks in Q2 2018 and held it in 6 quarters.
  • Magnetar Financial's Zymeworks position peaked at $393K in Q3 2018.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.